Associate Director, Clinical Supply Lead, ICN

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”, a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits.

This is work that transforms the lives of patients, and the careers of those who do it.

The Associate Director, Clinical Supply Lead provides, and is accountable for the day‑to‑day direction for forecasting, planning, and end‑to‑end (E2E) clinical supply chain activities across assigned compounds, assets, and studies within assigned Therapeutic Area (TA). This role ensures consistent, high‑quality execution of planning, supply readiness, and asset/study support through close partnership with peer Clinical Supply Leads, Trial Supply Managers (TSMs), and other intra‑study team members.

As a subject matter expert in the global use of investigational material, the Associate Director proactively recognizes and addresses technical and regulatory issues that may impact clinical development objectives. The role collaborates closely with cross‑functional teams, partners, stakeholders, and clinical leadership to deliver seamless supply solutions, drive analysis, efficiency, and innovation, and enable operational excellence throughout the clinical trial lifecycle.

This role assists the CSC leadership team in the effective collaboration, coordination, performance, and execution of CSC support to assigned assets/STP studies as well as the creation and sustainment of a data‑enabled CSL ecosystem integrated with common systems, tools, and emerging technologies (including, but not limited to, AI).

• Execute the strategic vision and direction for clinical asset planning activities and ensure alignment of assets/studies plans with established strategy, making recommendations for improvement, as needed.
• Provide oversight of clinical supply planning activities within assigned assets/studies and support continuous improvement of team execution.
• Provide support and guidance to matrix team members within assigned assets/studies and contribute to strengthening clinical supply planning capabilities.
• Serve as the single point of accountability for clinical supply planning and execution for assigned assets/studies.
• Support CSC leadership in preparing materials for governing bodies and other key stakeholders and provide subject‑matter expertise to inform asset‑related decisions.
• Execute CSL processes and contribute to continuous improvement efforts, including analysis of asset/study‑level KPIs and performance metrics recommendations for enhancements.
• Resolve issues within asset/study scope and elevate higher‑impact risks to leadership in a timely manner.
• Serve as the primary Clinical Supply Chain point of contact for assigned compounds and associated studies, leading communications regarding global supply strategy with study team as appropriate.
• Lead matrix teams to develop integrated cross‑functional strategies, resourcing, and implementation plans, ensuring continuous supply of investigational product in alignment with Project Team strategies, priorities, and objectives, and ensure timely delivery of quality clinical supplies to support clinical assets/studies.
• Oversee development of supply forecasts for complex studies through the evaluation, assessment, and refinement of the clinical development plan and protocol analysis. Ensures monitoring of inventory and drug utilization versus the forecast considering country requirements and logistical timelines.
• Partners with Global Development Operations (GDO) and Finance to operationalize the Clinical Development & Operations Planning (CDOP) process attending the Demand Alignment meetings and running the Supply Review meetings for the products that they have responsibility for.
• Assists with the adoption and sustainment of a data‑enabled ecosystem integrated with AI technologies.
• Appropriately and proactively…